April 30, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
Biotechnology

Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence

By Newsroom
Last updated: October 26, 2025
1 Min Read
Share


Patent eligibility under 35 U.S.C. § 101 should be a straightforward threshold question: any “new and useful process, machine, manufacture, or composition of matter” is eligible for protection. Yet over time, this once-clear principle has become anything but.

Although the statute itself has remained unchanged for two centuries, its interpretation has evolved dramatically through judicial decisions. And it is this common law precedent that has shaped the approach to the determination of patent subject matter eligibility.

Courts have carved out broad, judge-made exceptions to patentability, excluding laws of nature,…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

First Quarterly Stormwater Sampling Deadline of 2025 Approaching

Environmental Science
April 5, 2025

Advanced Wound Care OTC Market Technology Adoption and Forecast

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global…

April 29, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Eye Therapies v. Slayback Pharma – Fed. Cir. Enhances the Scope of “Consisting Essentially” |

In Eye Therapeutics, LLC, v. Slayback Pharma, LLC., Appeal no. 2023-2173, (Fed. Cir., June 30, 2025), a panel of Judges…

Biotechnology
July 18, 2025

Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute

In a pivotal ruling for patent damages and standard-essential patent (SEP) litigation, the Federal Circuit vacated a $300 million award…

Biotechnology
July 11, 2025

Stay Aware: Remote Employees Impact Venue Options In Patent Litigation

For many patent cases, the United States District Court hearing your patent dispute can have a big impact on case…

Biotechnology
October 19, 2025

PTO Defends its Recent Policy Changes Regarding Discretionary Denials

In the past few months, the U.S. Patent and Trademark Office (“PTO”) Acting Director has made substantial changes to the…

Biotechnology
December 28, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Advanced Wound Care OTC Market Technology Adoption and Forecast
April 29, 2026
Healthcare RPO Market Demand Rising Across Pharma and Hospitals
April 29, 2026
“Travel+” Strategy Accelerates SOUEAST’s Global Expansion
April 29, 2026
Sample Quality Control In Next-Generation Sequencing…
April 29, 2026

Life Science Magazines

Sample Quality Control In Next-Generation Sequencing…
April 29, 2026
Correlating NGS Success With Sample Input Quality: A Large…
April 29, 2026
Preventive Control Of Sequencing Through The Insert With The…
April 29, 2026
Quality Analysis Using The Agilent ProteoAnalyzer System And…
April 29, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?